Supplementary Data from Artificial Intelligence–Assisted Amphiregulin and Epiregulin IHC Predicts Panitumumab Benefit in <i>RAS</i> Wild-Type Metastatic Colorectal Cancer
Christopher J.M. Williams(Hospital for Special Surgery), Kandavel Shanmugam, Andrea Murányi, Xiaomeng Xu(Shanghai Jiao Tong University), Auranuch Lorsakul, Nicholas P. West(Johannes Gutenberg University Mainz), Faye Elliott(University of Leeds), Jenny F. Seligmann(University of Leeds), Philip Quirke(University of Leeds), Michel Seymour(University of Leeds), Christoph Guetter, Shalini Singh(King George's Medical University), Jennifer H. Barrett(University of Leeds), Isaac Bai(Roche (United States)), Sarah Brown(University of Leeds), Judith Pugh, Dongyao Yan(Tucson Medical Center), Michael Shires, Michael Barnes(European Organization for Nuclear Research), Liping Zhang, Wenwei Liu(Sun Yat-sen University), Uday Kurkure, Jim Martin, Kien Nguyen, Zhao Zuo, Susan D. Richman(University of Leeds)
Cited by 0
Related Papers
Leucovorin and Fluorouracil With or Without Oxaliplatin as First-Line Treatment in Advanced Colorectal Cancer
|Journal of Clinical Oncology|2000|3.8k
Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial
|The Lancet|2009|1.5k
Localised colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2020|1.3k
Value of Mismatch Repair, <i>KRAS</i> , and <i>BRAF</i> Mutations in Predicting Recurrence and Benefits From Chemotherapy in Colorectal Cancer
|Journal of Clinical Oncology|2011|678